Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,793,540
  • Shares Outstanding, K 1,420,911
  • Annual Sales, $ 9,913 M
  • Annual Income, $ -82,000 K
  • 60-Month Beta 0.88
  • Price/Sales 6.50
  • Price/Cash Flow 21.17
  • Price/Book 4.10
Trade BSX with:

Options Overview

Details
  • Implied Volatility 29.62%
  • Historical Volatility 23.14%
  • IV Percentile 47%
  • IV Rank 31.41%
  • IV High 50.68% on 02/01/21
  • IV Low 19.98% on 03/22/21
  • Put/Call Vol Ratio 0.77
  • Today's Volume 2,105
  • Volume Avg (30-Day) 4,636
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 213,041
  • Open Int (30-Day) 217,847

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.40
  • Number of Estimates 12
  • High Estimate 0.41
  • Low Estimate 0.40
  • Prior Year 0.37
  • Growth Rate Est. (year over year) +8.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.93 +11.41%
on 07/19/21
46.03 -0.93%
on 07/27/21
+2.84 (+6.64%)
since 06/30/21
3-Month
40.87 +11.57%
on 06/03/21
46.03 -0.93%
on 07/27/21
+2.00 (+4.59%)
since 04/30/21
52-Week
32.99 +38.22%
on 11/23/20
46.03 -0.93%
on 07/27/21
+6.66 (+17.10%)
since 07/30/20

Most Recent Stories

More News
Prosthetic Heart Valve Market Size 2021 By Trends Evaluation, Leading Players Updates, Consumer-Demand, Consumption, Recent Developments, Strategies, Market Impact and Forecast till 2027

The scope of the report includes a detailed study of global and regional markets for various Prosthetic Heart Valves Market with the reasons given for variations in the growth of the industry in certain...

ABT : 120.98 (-0.09%)
BSX : 45.60 (+0.62%)
CRY : 27.00 (-1.50%)
EW : 112.27 (+0.58%)
NVCN.TO : 1.05 (+2.94%)
STJ : 80.82 (+0.16%)
OPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down

OPKO Health's (OPK) second-quarter results benefit from strength in both its reportable segments.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
WST : 411.73 (+1.68%)
OPK : 3.44 (-7.77%)
Merit Medical's (MMSI) Q2 Earnings Top Estimates, '21 View Up

Merit Medical (MMSI), in the second quarter, benefits from revenue growth across both its segments as well as across all the product categories within its Cardiovascular unit.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
MMSI : 70.09 (+7.96%)
WST : 411.73 (+1.68%)
Integer Holdings (ITGR) Beats on Q2 Earnings, Ups 2021 View

Integer Holdings' (ITGR) second-quarter results reflect robust segmental performances along with strength in majority of the product lines.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
WST : 411.73 (+1.68%)
ITGR : 97.89 (-1.78%)
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline

Faster-than-expected vaccination uptake leads to a reduction in demand for COVID-19 testing for QIAGEN (QGEN) in Q2.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
QGEN : 52.79 (+1.09%)
WST : 411.73 (+1.68%)
Teleflex (TFX) Q2 Earnings Surpass Estimates, Margins Up

Teleflex (TFX) reports better-than-expected revenues with strong segmental and geographical performance driving the top line in second-quarter 2021.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
TFX : 397.43 (+0.36%)
WST : 411.73 (+1.68%)
Omnicell (OMCL) Q2 Earnings Top Estimates, 2021 EPS View Up

Omnicell (OMCL) reports better-than-expected revenues on strong segmental performance driving the top line in second-quarter 2021.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
OMCL : 146.50 (+3.29%)
WST : 411.73 (+1.68%)
Bio-Rad (BIO) Q2 Earnings Top Estimates, 2021 View Raised

Strength in Life Science and Clinical Diagnostics segments during the second quarter drove Bio-Rad (BIO) revenues.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
BIO : 739.51 (+4.58%)
WST : 411.73 (+1.68%)
IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up

Strength in CAG Diagnostics and Water businesses drove IDEXX's (IDXX) second-quarter revenues.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
IDXX : 678.53 (-3.64%)
WST : 411.73 (+1.68%)
Edwards Lifesciences (EW) Beats on Q2 Earnings, Margins Up

Strong sales growth across all four products along with steady improvement in surgical procedure volumes during the second quarter drove Edwards Lifesciences' (EW) revenues.

BSX : 45.60 (+0.62%)
LH : 296.15 (+0.51%)
EW : 112.27 (+0.58%)
WST : 411.73 (+1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

3rd Resistance Point 46.94
2nd Resistance Point 46.43
1st Resistance Point 46.02
Last Price 45.60
1st Support Level 45.10
2nd Support Level 44.59
3rd Support Level 44.18

See More

52-Week High 46.03
Last Price 45.60
Fibonacci 61.8% 41.05
Fibonacci 50% 39.51
Fibonacci 38.2% 37.97
52-Week Low 32.99

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar